Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/17/2026

1. JBHT
2. SPY
3. ASML
4. ATAI
5. NVDA
6. JNJ
7. NFLX
8. TSM
9. ASML:NA
10. UNH

Go back to Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
(NASDAQ: IMDX) Delayed: 4.71 -0.11 (2.28%)
Previous Close $4.82    52 Week High $ 
Open $4.55    52 Week Low $ 
Day High $4.94    P/E N/A 
Day Low $4.55    EPS $ 
Volume 182,365